Company
Board Member
2024-01-01–present
Board Member
Lb Pharmaceuticals Inc (LBRX)General Counsel
Lyell Immunopharma, Inc. (LYEL)Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
Organization not stated
Board Member
Proxy statement
2024-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
Company
Board Member
2024-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Lb Pharmaceuticals Inc (LBRX) | Chief Executive Officer | $568,750 | $11,884,985 |
| 2024 | Lb Pharmaceuticals Inc (LBRX) | Chief Executive Officer | $68,750 | $4,792,690 |
Earnings-call appearances and filed executive appointments or departures, newest first.